07:00 , Aug 22, 2011 |  BC Week In Review  |  Company News

3SBio management update

3SBio Inc. (NASDAQ:SSRX), Shenyang, China   Business: Hematology, Biosimilars   Resigned: David Chen as COO to become managing partner at 3SBio Ventures; his responsibilities will be allocated among senior management; and Yingfei Wei as CSO, Chief Technology...
07:00 , Aug 22, 2011 |  BC Week In Review  |  Financial News

3SBio Ventures financial update

Chinese biotech 3SBio Inc. (NASDAQ:SSRX, Shenyang, China) disclosed in its 2Q11 earnings that it formed 3SBio Ventures with Taizhou Oriental CMC Ltd. to make life science investments that support 3SBio's strategic interests. 3SBio, which...
07:00 , Aug 22, 2011 |  BioCentury  |  Finance

Venture import play

3SBio Inc. (NASDAQ:SSRX) is forming 3SBio Ventures, a Chinese government-supported entity that will make strategic investments in small to mid-sized U.S. life science plays. In exchange for equity, 3SBio hopes to obtain Chinese licensing rights...
00:09 , Aug 17, 2011 |  BC Extra  |  Company News

3SBio forms venture arm

Chinese biotech 3SBio Inc. (NASDAQ:SSRX) said it formed a venture partnership with Taizhou Oriental CMC Ltd. to make life science investments that support 3SBio's strategic interests. 3SBio, which did not disclose what types investments it...